Carson Wealth (CWM LLC)’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60K | Sell |
11,816
-12,278
| -51% | -$62.3K | ﹤0.01% | 3131 |
|
|
2025
Q1 | $127K | Buy |
24,094
+14,065
| +140% | +$74.1K | ﹤0.01% | 2230 |
|
|
2024
Q4 | $68K | Buy |
10,029
+2,246
| +29% | +$15.2K | ﹤0.01% | 2570 |
|
|
2024
Q3 | $51K | Buy |
7,783
+1,538
| +25% | +$10.1K | ﹤0.01% | 2681 |
|
|
2024
Q2 | $47K | Buy |
6,245
+19
| +0.3% | +$143 | ﹤0.01% | 2513 |
|
|
2024
Q1 | $62K | Hold |
6,226
| – | – | ﹤0.01% | 2160 |
|
|
2023
Q4 | $61K | Buy |
6,226
+42
| +0.7% | +$412 | ﹤0.01% | 2053 |
|
|
2023
Q3 | $47K | Hold |
6,184
| – | – | ﹤0.01% | 2106 |
|
|
2023
Q2 | $46K | Buy |
6,184
+39
| +0.6% | +$290 | ﹤0.01% | 2059 |
|
|
2023
Q1 | $41K | Buy |
6,145
+5,836
| +1,889% | +$38.9K | ﹤0.01% | 2018 |
|
|
2022
Q4 | $2K | Sell |
309
-8,681
| -97% | -$56.2K | ﹤0.01% | 3617 |
|
|
2022
Q3 | $96K | Buy |
8,990
+4,480
| +99% | +$47.8K | ﹤0.01% | 1348 |
|
|
2022
Q2 | $37K | Buy |
+4,510
| New | +$37K | ﹤0.01% | 1766 |
|
|
2022
Q1 | – | Sell |
-4,510
| Closed | -$77K | – | 3803 |
|
|
2021
Q4 | $77K | Buy |
+4,510
| New | +$77K | ﹤0.01% | 1404 |
|
|
2021
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2021
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2020
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2020
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2020
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2020
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2019
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2019
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2019
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 2807 |
|
|
2019
Q1 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 2807 |
|